Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.69 USD
Change Today +0.04 / 1.51%
Volume 757.1K
SNSS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jerome Birnbaum Ph.D.

Former Member of Scientific Advisory Board, Sunesis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 5 different industries.

See Board Relationships
74--

Background*

Dr. Jerome Birnbaum,Ph.D., serves as a Principal of Peartree Pharma R&D Consulting and is a Pharmaceutical R&D Consultant. Dr. Birnbaum is the Co-founder of Achillion Pharmaceuticals and has served as Senior Vice President of Research since February 2000. Dr. Birnbaum served as a Senior Vice President for Strategic R&D Operations for Bristol-Myers Squibb Pharmaceutical Research Institute from 1998 to 2000. From 1987 to January 2000, he was employed in various positions ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

2000-Present
Independent Director, Member of Innovation & Technology Committee, Member of Nominating Committee and Member of Corporate Governance & Compensation Committee

Education*

Doctorate
University of Cincinnati
Master's Degree
University of Cincinnati
Bachelor's Degree
Brooklyn College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNSS:US $2.69 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John R. Plachetka Pharm D.Co-Founder, Chairman, Chief Executive Officer and President
POZEN Inc.
$591.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.